HIV in the Southern United States. Atlanta, GA: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 2019. https://www.cdc.gov/hiv/pdf/policies/cdc-hiv-in-the-south-issue-brief.pdf. Accessed 19 December, 2022.
HIV Surveillance Report, 2020. Atlanta, GA: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 2022. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Accessed 6 September, 2022.
Regional Data: South. Atlanta, GA: AIDSVu, 2023. https://aidsvu.org/local-data/united-states/south/#:~:text=The%20rate%20of%20Black%20males,times%20that%20of%20White%20females. Accessed 1 June, 2023.
Race and Ethnicity in the South (Region). Excelsior, MN: Statistical Atlas, 2018. Available at: https://statisticalatlas.com/region/South/Race-and-Ethnicity#top. Accessed 1 June, 2023.
Reif SS, Safley D, McAllaster C. A closer look: Deep south has the highest HIV-related death rates in the United States. Durham, NC: Center for Health Policy & Inequalities Research at Duke University, 2015. https://scholarship.law.duke.edu/cgi/viewcontent.cgi?article=6410&=&context=faculty_scholarship&=&sei-redir=1&referer=https%253A%252F%252Fscholar.google.com%252Fscholar%253Fhl%253Den%2526as_sdt%253D0%25252C48%2526q%253DA%252Bcloser%252Blook%25253A%252BDeep%252Bsouth%252Bhas%252Bthe%252Bhighest%252BHIV-related%252Bdeath%252Brates%252Bin%252Bthe%252BUnited%252BStates%25252C%252B2017%2526btnG%253D#search=%22closer%20look%3A%20Deep%20south%20has%20highest%20HIV-related%20death%20rates%20United%20States%2C%202017%22. Accessed 19 December, 2022.
Age-adjusted mortality rate for HIV disease. San Francisco, CA: Kaiser Family Foundation, 2017. https://www.kff.org/hivaids/stateindicator/age-adjusted-hiv-mortality-rate/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Accessed 19 December, 2022.
Opioid Crisis Statistics. Washington, DC: U.S. Department of Health and Human Services, 2021. https://www.hhs.gov/opioids/about-the-epidemic/opioid-crisis-statistics/index.html. Accessed 8 October, 2022.
Provisional Drug Overdose Death Counts. Atlanta, GA: National Center for Health Statistics, 2022. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#citation. Accessed 6 September, 2022.
Unick GJ, Ciccarone D. US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations. International Journal of Drug Policy 2017; 46:112-9. https://doi.org/10.1016/j.drugpo.2017.06.003. Accessed 19 December, 2022.
Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry 2021; 34(4):344. https://doi.org/10.1097/YCO.0000000000000717. Accessed 1 June, 2023.
Humphreys K, Shover CL, Andrews CM, et al. Responding to the opioid crisis in North America and beyond: Recommendations of the Stanford–Lancet Commission. The Lancet 2022; 399(10324):555-604. https://doi.org/10.1016/S0140-6736(21)02252-2. Accessed 19 December, 2022.
McGranahan DA, Parker TS. The Opioid Epidemic: A Geography in Two Phases. Economic Research Service. Publication number 287, 2021. https://www.ers.usda.gov/webdocs/publications/100833/err-287.pdf?v=1708. Accessed 19 December, 2022.
Cano M. Racial/ethnic differences in US drug overdose mortality, 2017–2018. Addictive Behaviors 2021; 112:106625. https://doi.org/10.1016/j.addbeh.2020.106625. Accessed 19 December, 2022.
El-Bassel N, Shoptaw S, Goodman-Meza D, Ono H. Addressing long overdue social and structural determinants of the opioid epidemic. Drug and Alcohol Dependence 2021; 222:108679. https://doi.org/10.1016/j.drugalcdep.2021.108679. Accessed 19 December, 2022.
Shiels MS, Freedman ND, Thomas D, et al. Trends in US drug overdose deaths in non-Hispanic black, Hispanic, and non-Hispanic white persons, 2000–2015. Annals of Internal Medicine 2018;168(6):453-5. https://doi.org/10.7326/2FM17-1812. Accessed 19 December, 2022.
Singer M, Bulled N, Ostrach B, et al. Syndemics and the biosocial conception of health. The Lancet 2017;389(10072):941-50. https://doi.org/10.1016/S0140-6736(17)30003-X. Accessed 1 June, 2023.
Reif S, Safley D, McAllaster C, et al. State of HIV in the US Deep South. Journal of Community Health 2017;42(5):844-53. https://doi.org/10.1007/s10900-017-0325-8. Accessed 19 December, 2022.
Adimora AA, Ramirez C, Schoenbach VJ, et al. Policies and politics that promote HIV infection in the Southern United States. AIDS 2014;28(10):1393. https://doi.org/10.1097/2FQAD.0000000000000225. Accessed 19 December, 2022.
Kimmel AD, Masiano SP, Bono RS, et al. Structural barriers to comprehensive, coordinated HIV care: geographic accessibility in the US South. AIDS Care 2018; 30(11):1459-68. https://doi.org/10.1080/2F09540121.2018.1476656. Accessed 19 December, 2022.
Status of State Medicaid Expansion Decisions: Interactive Map. San Francisco, CA: Kaiser Family Foundation, 2022. https://www.kff.org/medicaid/issue-brief/status-of-state-medicaid-expansion-decisions-interactive-map/. Accessed 19 December, 2022.
Baugher AR, Whiteman A, Jeffries IV WL, et al. Black men who have sex with men living in states with HIV criminalization laws report high stigma, 23 US cities, 2017. AIDS 2021; 35(10):1637-45. https://doi.org/10.1097/QAD.0000000000002917. Accessed 19 December, 2022.
English D, Carter JA, Boone CA, et al. Intersecting structural oppression and Black sexual minority men's health. American Journal of Preventive Medicine 2021; 60(6):781-91. https://doi.org/10.1016/j.amepre.2020.12.022. Accessed 19 December, 2022.
Knight KR. Structural factors that affect life contexts of pregnant people with opioid use disorders: The role of structural racism and the need for structural competency. Women's Reproductive Health 2020;7(3):164-71. https://doi.org/10.1080/23293691.2020.1780400. Accessed i June, 2023.
Merrill JO, Rhodes LA, Deyo RA, et al. Mutual mistrust in the medical care of drug users: The keys to the “narc” cabinet. Journal of General Internal Medicine 2002;17:327-33.: https://doi.org/10.1007/s11606-002-0034-5. Accessed 1 June, 2023.
Kunins HV. Structural racism and the opioid overdose epidemic: The need for antiracist public health practice. Journal of Public Health Management and Practice 2020;26(3):201-5. https://doi.org/10.1097/PHH.0000000000001168. Accessed 1 June, 2023.
Principles of Harm Reduction. New York, NY: National Harm Reduction Coalition, 2020. Available at https://harmreduction.org/wp-content/uploads/2020/08/NHRC-PDF-Principles_Of_Harm_Reduction.pdf. Accessed 19 December, 2022.
Des Jarlais DC, Perlis T, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996. American Journal of Public Health 1998;88(12): 1801-6. https://doi.org/10.2105/AJPH.88.12.1801. Accessed 19 December, 2022.
Article CAS PubMed Google Scholar
Des Jarlais DC, Perlis T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS 2005; 19:S20-5. https://doi.org/10.1097/01.aids.0000192066.86410.8c. Accessed 19 December, 2022.
Des Jarlais DC, Arasteh K, McKnight C, et al. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City. Drug and Alcohol Dependence 2009; 101(1-2):88-91. https://doi.org/10.1016/j.drugalcdep.2008.11.007. Accessed 19 December, 2022.
Strathdee SA, Ricketts EP, Huettner S, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug and Alcohol Dependence 2006; 83(3):225-32. https://doi.org/10.1016/j.drugalcdep.2005.11.015. Accessed 19 December, 2022.
Wodak A, Maher L. The effectiveness of harm reduction in preventing HIV among injecting drug users. New South Wales Public Health Bulletin 2010; 21(4):69-73. https://doi.org/10.1071/NB10007. Accessed 19 December, 2022.
Abdul-Quader AS, Feelemyer J, Modi S, et al. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: A systematic review. AIDS and Behavior 2013; 17(9):2878-92. https://doi.org/10.1007/s10461-013-0593-y. Accessed 19 December, 2022.
Hagan H, Jarlais DC, Friedman SR, et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health 1995; 85(11):1531-7. https://doi.org/10.2105/AJPH.85.11.1531. Accessed 19 December, 2022.
Article CAS PubMed Google Scholar
Heimer R, Khoshnood K, Bigg D, et al. Syringe use and reuse: Effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 1998; 18:S37-44. https://doi.org/10.1097/00042560-199802001-00008. Accessed 19 December, 2022.
Bornstein KJ, Coye AE, St Onge JE, et al. Hospital admissions among people who inject opioids following syringe services program implementation. Harm Reduction Journal 2020; 17(1):1-5. https://doi.org/10.1186/s12954-020-00376-1. Accessed 19 December, 2022.
Naumann RB, Durrance CP, Ranapurwala SI, et al. Impact of a community-based naloxone distribution program on opioid overdose death rates. Drug and Alcohol Dependence 2019; 204:107536. https://doi.org/10.1016/2Fj.drugalcdep.2019.06.038. Accessed 19 December, 2022.
Rowe C, Wheeler E, Stephen Jones T, et al. Community-based response to fentanyl overdose outbreak, San Francisco, 2015. Journal of Urban Health 2019; 96(1):6-11. https://doi.org/10.1007/2Fs11524-018-0250-x. Accessed 19 December, 2022.
Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ 2013;346. https://doi.org/10.1136/bmj.f174. Accessed 19 December, 2022.
Carlberg-Racich S. Harm reduction interventions in HIV care: A qualitative exploration of patient and provider perspectives. PeerJ 2016; 4:e1932. https://doi.org/10.7717/peerj.1932. Accessed 19 December, 2022.
Article CAS PubMed Google Scholar
Pinto RM, Chen Y, Park SE. A client-centered relational framework on barriers to the integration of HIV and substance use services: A systematic review. Harm Reduction Journal 2019; 16(1):1-2. https://doi.org/10.1186/s12954-019-0347-x. Accessed 19 December, 2022.
Brown MJ, Adeagbo O. Trauma-informed HIV care interventions: Towards a holistic approach. Current HIV/AIDS Reports 2022; 19:177-183. https://doi.org/10.1007/s11904-022-00603-3. Accessed 19 December, 2022.
Hopper EK, Bassuk EL, Olivet J. Shelter from the storm: Trauma-informed care in homelessness services settings. The Open Health Services and Policy Journal 2010; 3(1): 80-100. http://dx.doi.org/%2010.2174/1874924001003010080. Accessed 19 December, 2022.
Stanton MC, Ali SB, McCormick K. Harm reduction implementation among HIV service organizations (HSOs) in the US south: A policy context analysis and results from a survey of HSOs. BMC Health Services Research. 2022 ;22(1):913. https://doi.org/10.1186/s12913-022-08277-8. Accessed 1 August, 2023.
Stanton MC, Ali SB,
Comments (0)